Understanding the Role of Sleep in Complicated Grief
| Status: | Recruiting |
|---|---|
| Conditions: | Insomnia Sleep Studies |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 25 - 60 |
| Updated: | 7/21/2018 |
| Start Date: | July 2, 2018 |
| End Date: | April 2020 |
| Contact: | Julia Spandorfer |
| Email: | Julia.Spandorfer@nyumc.org |
| Phone: | 646-754-4895 |
Understanding the Role of Sleep in Complicated Grief: A Pilot Study
The purpose of this study is to learn more about the causes of Complicated Grief (CG) in
those who experience the loss of a loved one. This study aims at learning more about the
sleep patterns and emotions in participants with CG as compared to those who have lost a
loved one but do not have CG.
This study will consist of two aims:
Aim 1: Approximately 10 complicated grief (CG) patients and 10 controls (without a current
psychiatric diagnosis) will complete a 3-day home polysomnography (PSG) sleep assessment in
addition to several self-report sleep and psychiatric measures.
Aim 2: Approximately 10 CG patients (subsample from Aim 1) will complete 16 weekly sessions
of complicated grief therapy (CGT) in addition to completion of repeated PSG assessments and
self-report sleep and psychiatric measures.
those who experience the loss of a loved one. This study aims at learning more about the
sleep patterns and emotions in participants with CG as compared to those who have lost a
loved one but do not have CG.
This study will consist of two aims:
Aim 1: Approximately 10 complicated grief (CG) patients and 10 controls (without a current
psychiatric diagnosis) will complete a 3-day home polysomnography (PSG) sleep assessment in
addition to several self-report sleep and psychiatric measures.
Aim 2: Approximately 10 CG patients (subsample from Aim 1) will complete 16 weekly sessions
of complicated grief therapy (CGT) in addition to completion of repeated PSG assessments and
self-report sleep and psychiatric measures.
Inclusion Criteria:
- Bereaved due to death of a loved one >= 6 months prior (for both CG and control
groups)
- For CG participants: grief is primary psychiatric problem with ICG >= 30 (threshold
symptoms; for CG group only). Controls will be free of current psychiatric disorders
with the exception of specific phobia.
- Normal or corrected vision
Exclusion Criteria:
- Psychiatric or sleep medications in the past 4 weeks (past 6 weeks for fluoxetine)
- Concurrent grief or exposure based therapy
- Lifetime bipolar, psychosis, significant neurological disorders
- Past 6 months of alcohol/substance use disorder
- Unstable medical illness
- Serious safety concerns of suicide or homicide
- Pregnant or nursing
- Overnight shift work
- > 4 caffeinated or > 11 alcoholic beverages per week
- Screening reveals OSA defined as an apnea hypopnea index with 4% desaturation (AHI4%)
≥15 or an AHI4% ≥ with an Epworth >10
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Naomi Simon, MD
Phone: 646-754-4895
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
